D. Western Therapeutics Institute
4576
Rentracks
6045
Itamiarts
168A
Washington Hotel
4691
Next Generation Technology Group
319A
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.51%93.55B | 53.44%82.8B | 8.24%307.55B | 32.00%104.3B | 16.94%77B | -9.09%72.3B | -9.69%53.96B | 11.96%284.14B | 7.49%79.02B | 2.57%65.84B |
Cost of revenue | 10.64%26.93B | 33.66%25.1B | -0.72%98.91B | 18.65%32.97B | 7.01%24.34B | -16.96%22.82B | -13.12%18.78B | -0.14%99.63B | -2.49%27.79B | -9.13%22.75B |
Gross profit | 26.53%66.62B | 64.00%57.7B | 13.08%208.64B | 39.24%71.33B | 22.19%52.66B | -4.95%49.48B | -7.74%35.18B | 19.80%184.51B | 13.80%51.22B | 10.05%43.09B |
Operating expense | 23.21%27.48B | 33.57%24.32B | 17.62%87.15B | 26.38%25.2B | 18.40%22.3B | 14.20%21.44B | 10.08%18.21B | 18.55%74.09B | 19.05%19.94B | 18.72%18.84B |
Operating profit | 28.96%39.15B | 96.65%33.38B | 10.03%121.49B | 47.44%46.13B | 25.14%30.35B | -15.75%28.04B | -21.40%16.97B | 20.65%110.41B | 10.69%31.29B | 4.14%24.26B |
Net non-operating interest income (expenses) | 12.50%9M | -33.33%8M | 71.74%79M | 40.00%21M | -11.11%8M | 245.45%38M | 9.09%12M | -6.12%46M | 15.38%15M | -40.00%9M |
Non-operating interest income | 12.50%9M | -33.33%8M | 71.74%79M | 40.00%21M | -11.11%8M | 245.45%38M | 9.09%12M | -6.12%46M | 15.38%15M | -40.00%9M |
Net investment income | 242.97%2.5B | -103.85%-39M | -230.54%-889M | -46.17%260M | 0.11%-1.75B | -142.36%-413M | 4.00%1.01B | 163.47%681M | 4,290.91%483M | -703.67%-1.75B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 10M | ||||||||
Income from associates and other participating interests | 642.86%52M | 138.46%93M | -26.56%141M | 6,800.00%67M | -75.00%7M | -61.64%28M | -57.61%39M | -58.35%192M | -104.76%-1M | 75.00%28M |
Special income (charges) | 97.72%-173M | -483.33%-175M | -2,053.73%-7.85B | -140.29%-224M | -8,230.77%-7.58B | 36.67%-19M | 9.09%-30M | 265.43%402M | 1,234.69%556M | 18.02%-91M |
Less:Impairment of capital assets | 22.22%11M | 25.00%10M | 5.71%37M | 11.11%10M | 0.00%9M | 11.11%10M | 0.00%8M | -23.91%35M | -18.18%9M | -25.00%9M |
Less:Other special charges | 285.71%162M | 650.00%165M | 157.40%287M | 137.88%214M | 121.05%42M | -57.14%9M | -12.00%22M | -353.81%-500M | -1,586.84%-565M | -80.81%19M |
Less:Write off | ---- | ---- | 11,852.38%7.53B | --0 | ---- | ---- | ---- | --63M | --0 | ---- |
Other non-operating income (expenses) | -61.12%327M | 45.86%194M | 54.71%1.61B | -46.15%203M | 1,052.05%841M | -12.02%432M | 34.34%133M | -32.64%1.04B | 47.27%377M | -91.96%73M |
Income before tax | 91.38%41.87B | 84.45%33.46B | 1.59%114.58B | 41.94%46.45B | -2.87%21.88B | -19.23%28.11B | -20.22%18.14B | 22.26%112.79B | 14.78%32.73B | -5.77%22.52B |
Income tax | 72.75%10.02B | 77.14%9.69B | 1.65%30.36B | 56.29%11.01B | -2.99%5.8B | -20.40%8.09B | -18.25%5.47B | 14.90%29.87B | -9.76%7.04B | -14.23%5.98B |
Net income | 98.10%31.84B | 87.62%23.77B | 1.56%84.21B | 38.01%35.44B | -2.83%16.08B | -18.74%20.02B | -21.05%12.67B | 25.15%82.91B | 24.02%25.68B | -2.28%16.54B |
Net income continuous operations | 98.10%31.85B | 87.60%23.77B | 1.57%84.21B | 38.01%35.45B | -2.82%16.08B | -18.75%20.02B | -21.04%12.67B | 25.15%82.91B | 24.02%25.68B | -2.29%16.54B |
Noncontrolling interests | 800.00%36M | 618.18%57M | -77.27%5M | 54.55%17M | 200.00%4M | -171.43%-5M | -237.50%-11M | -53.19%22M | 0.00%11M | -133.33%-4M |
Net income attributable to the company | 97.92%31.81B | 86.98%23.71B | 1.59%84.21B | 37.99%35.43B | -2.86%16.07B | -18.71%20.03B | -20.93%12.68B | 25.20%82.89B | 24.04%25.67B | -2.19%16.55B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 97.92%31.81B | 86.98%23.71B | 1.59%84.21B | 37.99%35.43B | -2.86%16.07B | -18.71%20.03B | -20.93%12.68B | 25.20%82.89B | 24.04%25.67B | -2.19%16.55B |
Gross dividend payment | ||||||||||
Basic earnings per share | 97.88%293.54 | 86.91%218.85 | 1.54%777.29 | 37.94%326.99 | -2.91%148.34 | -18.73%184.87 | -20.96%117.09 | 25.14%765.47 | 24.01%237.05 | -2.22%152.79 |
Diluted earnings per share | 98.61%293.5213 | 87.56%218.85 | 1.48%774.26 | 37.82%325.61 | -2.95%147.79 | -18.78%184.18 | -20.99%116.68 | 25.17%762.98 | 23.99%236.26 | -2.22%152.29 |
Dividend per share | 0 | 0 | 0.55%307 | 9.31%231 | 0 | -19.15%76 | 0 | 13.37%305.3333 | 4.11%211.3333 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |